Cognitive studies in patients with TBI and hydrocephalus have also identified impairments in problem-solving [7], executive function [8], short-term and working memory [9, 10]
BD Ultra-Fine Nano (Becton, Dickinson)
A 2021 randomized controlled trial demonstrated that exenatide, a GLP-1 receptor agonist, significantly slowed cognitive decline in patients with early-stage Parkinsons disease compared to a placebo group (Athauda et al., 2021)
Compounded Semaglutide as a Personalized Alternative Compounded semaglutide from PlexusDx-partnered 503A pharmacies offers a precision alternative when Wegovy plateaus
Recent studies have recently shown that miR-137 and miR-15 b can reverse the neurotoxicity induced by A abnormal metabolism in animal and cell lines (He et al., 2017
Of 544 screened papers, the reviewers identified 36 studies meeting inclusion criteria 35 preclinical and one human study